Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Prowse

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Journal of Clinical Apheresis|January 1, 1995
Effect of therapeutic plasmapheresis on coagulation parametersC V Prowse, S J Urbaniak
British Journal of Haematology|January 1, 1981
The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the South-East of ScotlandC V Prowse, J D Cash
Biochimica Et Biophysica Acta|February 22, 1977
The gamma-carboxy glutamic acid content of human and bovine prothrombin following warfarin treatmentM P Esnouf, C V Prowse
Thrombosis and Haemostasis|February 29, 1980
In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparationsF Toolis, G McKay, C V Prowse
Medical Laboratory Sciences|July 1, 1988
Human coagulation factor IX: direct depletion and recovery from plasma, using immobilised monoclonal antibodyH Bessos, C V Prowse, K James
Thrombosis and Haemostasis|February 29, 1980
In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assaysC V Prowse, A Chirnside, R A Elton
Thrombosis Research|April 15, 1987
Heparin-induced platelet factor 4 release in patients with atherosclerotic peripheral vascular diseaseM G Dunlop, C V Prowse, J Dawes
Brain Research|May 7, 1984
A hypothalamic-pituitary system that stimulates the release of plasminogen activator in the ratC V Prowse, R C Dow, G Fink
Thrombosis and Haemostasis|October 30, 1985
The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urineJ Dawes, C V Prowse, D S Pepper
Thrombosis Research|December 1, 1986
Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assayJ Dawes, C V Prowse, D S Pepper
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Apheresis|January 1, 1995
Effect of therapeutic plasmapheresis on coagulation parametersC V Prowse, S J Urbaniak
British Journal of Haematology|January 1, 1981
The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the South-East of ScotlandC V Prowse, J D Cash
Biochimica Et Biophysica Acta|February 22, 1977
The gamma-carboxy glutamic acid content of human and bovine prothrombin following warfarin treatmentM P Esnouf, C V Prowse
Thrombosis and Haemostasis|February 29, 1980
In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparationsF Toolis, G McKay, C V Prowse
Medical Laboratory Sciences|July 1, 1988
Human coagulation factor IX: direct depletion and recovery from plasma, using immobilised monoclonal antibodyH Bessos, C V Prowse, K James
Thrombosis and Haemostasis|February 29, 1980
In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assaysC V Prowse, A Chirnside, R A Elton
Thrombosis Research|April 15, 1987
Heparin-induced platelet factor 4 release in patients with atherosclerotic peripheral vascular diseaseM G Dunlop, C V Prowse, J Dawes
Brain Research|May 7, 1984
A hypothalamic-pituitary system that stimulates the release of plasminogen activator in the ratC V Prowse, R C Dow, G Fink
Thrombosis and Haemostasis|October 30, 1985
The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urineJ Dawes, C V Prowse, D S Pepper
Thrombosis Research|December 1, 1986
Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assayJ Dawes, C V Prowse, D S Pepper
Pageof 10